Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults
Funding was provided by the Biomedical Advanced Research and Development Authority (BARDA), USA, under contract 75A50119C00055.
Authors
- Courtney L. Finch (ORCID: https://orcid.org/0000-0002-3674-3282)
- Michael Stevenson
- Jocelyn Jakubik
- Ekaterina Vert-Wong (ORCID: https://orcid.org/0000-0002-1806-4892)
- Thomas H. King
- Roxana Rustomjee
Institutions
- Oklahoma Blood Institute (US)
- Sabin Vaccine Institute (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105889
- Primary Topic
- Viral Infections and Outbreaks Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00